TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive President Clinton Seeks 8% Increase For NCI; Most Institute Take Cuts In $10 Bll. NIH Budget April 16, 1993
TCL Archive ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic. April 9, 2010
TCL Archive One Year Later, Cancer Centers And NCI are Getting Along Just Fine, AACI Learns July 27, 1990